AMVGX | VMVAX | AMVGX / VMVAX | |
Total Expense Ratio | 0.78 | 0.07 | 1,114% |
Annual Report Gross Expense Ratio | 0.78 | 0.07 | 1,114% |
Fund Existence | 8 years | 14 years | - |
Gain YTD | 4.100 | 2.976 | 138% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 6.91B | 30.6B | 23% |
Annual Yield % from dividends | 1.76 | 2.26 | 78% |
Returns for 1 year | 0.82 | 6.89 | 12% |
Returns for 3 years | 6.89 | 25.19 | 27% |
Returns for 5 years | 18.12 | 67.02 | 27% |
Returns for 10 years | N/A | 89.45 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
ASIAX | 29.92 | 0.18 | +0.61% |
Invesco EQV Asia Pacific Equity A | |||
NESYX | 62.69 | 0.09 | +0.14% |
Natixis US Equity Opportunities Y | |||
CGFFX | 81.85 | 0.04 | +0.05% |
American Funds Growth Fund of Amer 529F | |||
VVPSX | 12.24 | -0.03 | -0.24% |
Vulcan Value Partners Small Cap | |||
JFNNX | 65.40 | -0.30 | -0.46% |
Janus Henderson Global Life Sciences N |